CELLINK Establishes Center of Excellence in India Focused on 3D Bioprinting
CELLINKa world leader in the development of 3D bio-printers, and The Indian Institute of Science (IISc) are partnering to establish a Center of Excellence (CoE) for 3D Bioprinting in Bengaluru, India.
The CoE, the first of its kind in the region, will be hosted at IISc’s Center for Biosystems Science and Engineering (BSSE).
The Center of Excellence will provide access to 3D bioprinting systems, allowing researchers to accelerate their work on critical applications with the ultimate goal of improving health outcomes.
“We are delighted to welcome this CoE to the institute, which will help initiate cutting-edge research in an emerging technological field with immense potential for human health,” said Professor Narendra Dixit, President of the BSSE.
3D bioprinting is the application of additive manufacturing techniques to living cells, growth factors and/or biomaterials to fabricate biomedical parts, often with the goal of mimicking the characteristics of natural tissues.
A wide range of bioprinting techniques and biomaterials are covered by 3D bioprinting. It can currently be used to print models of tissues and organs that help research potential drugs and treatments.
Several CELLINK 3D bio-printers will be housed at the new CoE. It will serve as a hub for several research initiatives and training activities in the field of technology. IISc and CELLINK will work together to organize workshops aimed at providing researchers at the institute and elsewhere with the skills to use 3D bioprinting.
Both groups will also undertake and advise on research projects in multiple applications spanning the fields of tissue engineering, drug discovery, materials science and regenerative/personalized medicine. The CoE will focus on work around the heart, bone cartilage and cancer.
“It is an honor to collaborate with one of the most important scientific institutes in India. India has long been at the forefront of scientific discovery, and with the exceptional talent and deep-rooted passion for translating research from the bench to the clinic, we are confident that this center of excellence will have an impact on research advances in heart, bone, cartilage and cancer,” said Cecilia Edebo, CEO of CELLINK.
Bengaluru is also home to a new state-of-the-art 3D printing facility at Bengaluru Airport City. The facility houses a production center and experience area that will train individuals and students in 3D printing. It will also be an incubation center for those who want to imagine new solutions.
Want to discuss ? Join the conversation on the Global Additive Manufacturing Community Discord.
Get your FREE print subscription to TCT Magazine.